|
[1]
|
Olson, G. and Davis, A.M. (2020) Diagnosis and Treatment of Adults with Community-Acquired Pneumonia. JAMA, 323, 885-886. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Zheng, X., Huang, Z., Wang, D., Pan, S., Zhao, Y., Li, J., et al. (2022) A New Haematological Model for the Diagnosis and Prognosis of Severe Community-Acquired Pneumonia: A Single-Center Retrospective Study. Annals of Translational Medicine, 10, Article No. 881. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Spasovska, K., Grozdanovski, K., Milenkovic, Z., Bosilkovski, M., Cvetanovska, M., Kuzmanovski, N., et al. (2021) Evaluation of Severity Scoring Systems in Patients with Severe Community Acquired Pneumonia. Romanian Journal of Internal Medicine, 59, 394-402. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
张慧芳, 张雪, 沙玉霞, 等. 血清及支气管肺泡灌洗液中sTREM-1水平、APACHEII评分及SOFA评分对重症肺炎患儿病情及预后评价[J]. 中国当代儿科杂志, 2020, 22(6): 626-631.
|
|
[5]
|
中华医学会呼吸病学分会. 中国成人社区获得性肺炎诊断和治疗指南(2016年版) [J]. 中华结核和呼吸杂志, 2016, 39(4): 253-279.
|
|
[6]
|
Patel, S. (2021) Calculated Decisions: PSI/PORT Score: Pneumonia Severity Index for Community-Acquired Pneumonia. Emergency Medicine Practice, 23, CD2-CD3.
|
|
[7]
|
Putowski, Z., Czok, M., Polok, K., Guidet, B., Jung, C., Bruno, R.R., et al. (2023) Reporting SOFA in Research: We Should Always Present Each of the SOFA Subscores. Anaesthesiology Intensive Therapy, 55, 326-329. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Schneider, J.L., Rowe, J.H., Garcia-de-Alba, C., Kim, C.F., Sharpe, A.H. and Haigis, M.C. (2021) The Aging Lung: Physiology, Disease, and Immunity. Cell, 184, 1990-2019. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Sungurlu, S. and Balk, R.A. (2018) The Role of Biomarkers in the Diagnosis and Management of Pneumonia. Clinics in Chest Medicine, 39, 691-701. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
华海湖, 吴宗劲, 罗朝湖. 血清C反应蛋白、降钙素原在重症肺炎中的变化及临床意义[J]. 牡丹江医学院学报, 2020, 41(4): 59-60+129.
|
|
[11]
|
西俊英. 血清PCT、IL-6、ET-1水平联合检测在重症肺炎继发呼吸衰竭诊断中的效能[J]. 中国民康医学, 2024, 36(23): 107-109.
|
|
[12]
|
Dolci, A., Robbiano, C., Aloisio, E., Chibireva, M., Serafini, L., Falvella, F.S., et al. (2020) Searching for a Role of Procalcitonin Determination in COVID-19: A Study on a Selected Cohort of Hospitalized Patients. Clinical Chemistry and Laboratory Medicine (CCLM), 59, 433-440. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
吴国志. 乳酸及C反应蛋白联合检测对重症肺炎的诊断价值[J]. 深圳中西医结合杂志, 2017, 27(18): 82-83.
|
|
[14]
|
柯嘉鸣, 陈海燕. 血清相关指标结合CURB-65评分评估重症肺炎预后的价值[J]. 中华灾害救援医学, 2024, 11(1): 20-22+33.
|
|
[15]
|
冷婧, 魏首栋, 庞工力, 等. 血清同型半胱氨酸叶酸C反应蛋白水平与冠心病严重程度相关性[J]. 中国药物与临床2021, 21(12): 2076-2079.
|
|
[16]
|
赖碧珠. CRP、WBC、ESR及痰培养在老年肺部感染中的临床应用价值[J]. 吉林医学, 2025, 46(10): 2463-2465.
|
|
[17]
|
张丽英, 肖毅, 张红, 等. 乳酸清除率、C反应蛋白和CURB-65评分在评估急诊重症肺炎预后中的作用[J]. 北京医学, 2021, 43(5): 460-462+465.
|
|
[18]
|
郭亚威, 王萌, 朱丹丹, 等. 降钙素原联合CURB-65评分对老年社区获得性肺炎患者预后的评估价值[J]. 中国综合临床, 2019, 35(1): 73-76.
|
|
[19]
|
Kolditz, M., Braeken, D., Rohde, G. and Ewig, S. (2016) Severity Assessment and the Immediate and Long-Term Prognosis in Community-Acquired Pneumonia. Seminars in Respiratory and Critical Care Medicine, 37, 886-896. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
殷胜禄. SOFA评分联合降钙素原在脓毒症早期诊断及预后应用[J]. 中华医院感染学杂志, 2013, 23(11): 2536-2538.
|